Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities Together with their partners, Quantum Genomics is taking all necessary measures to maintain its clinical development activities while ensuring that the safety of its staff and enrolled patients remains its top priority. Read the press release Previous Post (p) Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights Next Post (n) Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients